Navigation Links
J. Craig Venter, Ph.D. to Receive National Medal of Science From President Obama

ROCKVILLE, Md., Sept. 18 /PRNewswire-USNewswire/ -- J. Craig Venter, Ph.D., founder, president and chairman of the J. Craig Venter Institute (JCVI), has been named a recipient of this year's National Medal of Science. Dr. Venter will be awarded the Medal from President Obama on October 7 at a White House ceremony.

The National Medal of Science, the highest honor awarded to scientists by the United States government, was created by statute in 1959 and is administered for the White House by the National Science Foundation. Awarded annually, the Medal recognizes individuals who have made outstanding contributions to science and engineering. Nominees are selected by a committee of Presidential appointees based on their advanced knowledge in, and contributions to, the biological, behavioral/social, and physical sciences, as well as chemistry, engineering, computing, and mathematics.

According to the official citation, Dr. Venter is being recognized for his dedication to the advancement of the science of genomics, his contributions to the understanding of its implications for society, and his commitment to the clear communication of information to the scientific community, the public, and policymakers.

Dr. Venter and his teams have been continuous pioneers in the field of genomics. Beginning in the late 1980's they were the first to successfully use new automated DNA sequencers to sequence human genes. They then used these same technologies to develop and publish in 1991 Expressed Sequence Tags (ESTs), Dr. Venter's new method to rapidly discover human genes. Since then more than 65 million EST's have been generated by the scientific community from a broad range of species.

In 1995 he and his team sequenced the first full genome of a free living organism, the bacteria Haemophilus influenzae, by a new method they developed called "whole genome shotgun sequencing". This first genome led to the rapid and accurate decoding of hundreds of important genomes including human viral and bacterial pathogens, environmental microbes, insect, plant and mammalian genomes. More than 95% of genomes sequenced have been done using Dr Venter's methods. Only five years after developing this new method, Dr Venter's team announced the first draft human genome in 2000. They continued their work on sequencing and analyzing the human genome and published the first complete diploid genome in 2007.

Dr. Venter has since applied these same DNA sequencing approaches to catalogue the genomes of the microbes living in a variety of environments. The Venter Institute's Sorcerer II Expedition has discovered more than 20 million new genes from microbes in the world's oceans. Other environments including the human gut, mouth and skin are yielding similarly important new insights into the microbes inhabiting the human body. These research projects helped to begin the new fields known as environmental genomics and metagenomics.

Dr. Venter and colleagues also pioneered the new field of synthetic genomics and are trying to create the first world's first synthetic cell.

In addition to his work and leadership at the Venter Institute, Dr. Venter is also founder and CEO of Synthetic Genomics Inc, a privately held company applying genomic-driven solutions to address a variety for global challenges starting first with energy and the environment. Dr. Venter is the author of more than 250 major research articles and is among the most cited scientists in the world. He is also the recipient of numerous honorary degrees, scientific awards and a member of many prestigious scientific organizations including the National Academy of Sciences.

About the J. Craig Venter Institute

The JCVI is a not-for-profit research institute in Rockville, MD and San Diego, CA dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 400 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501 (c) (3) organization. For additional information, please visit

SOURCE J. Craig Venter Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Craig Johnson Joins Ardea Biosciences Board of Directors
2. J. Craig Venter Institute Names Robert Friedman, Ph.D., Deputy Director of West Coast Facility
3. J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology
4. Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System
5. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
8. DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Companys Scientific Advisory Board
9. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
10. TopSpin Medical Appoints Cindy Setum, Ph.D., Vice President Clinical Affairs
11. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... The Global Genomics Industry ... and in-depth study on the current state of ... ) , The report provides ... classifications, applications and industry chain structure. The Genomics ... including development trends, competitive landscape analysis, and key ...
(Date:11/24/2015)... DIEGO , Nov. 24, 2015 Halozyme Therapeutics, Inc. ... Healthcare Conference in New York on Wednesday, ... Helen Torley , president and CEO, will provide a corporate ... New York at 1:00 p.m. ET/10:00 a.m. PT ... and investor relations, will provide a corporate overview. --> ...
Breaking Biology Technology:
(Date:10/29/2015)... , October 29, 2015 ... biometric authentication company focused on the growing mobile ... wallet announces that StackCommerce, a leading marketplace to ... featuring the Wocket® smart wallet on StackSocial for ... ) ("NXT-ID" or the "Company"), a biometric authentication ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):